Axe Compute Inc (NASDAQ:AGPU – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $6.66 and traded as low as $5.85. Axe Compute shares last traded at $6.05, with a volume of 526,337 shares trading hands.
Analyst Upgrades and Downgrades
AGPU has been the subject of several recent analyst reports. JonesTrading raised shares of Axe Compute to a “strong-buy” rating in a report on Saturday, September 26th. Wall Street Zen upgraded shares of Axe Compute from a “sell” rating to a “hold” rating in a report on Monday, August 24th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Axe Compute in a research report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Axe Compute presently has a consensus rating of “Moderate Buy”.
View Our Latest Analysis on Axe Compute
Axe Compute Trading Down 18.7%
The company has a market capitalization of $70.12 million, a P/E ratio of -1.05 and a beta of 3.84. The firm has a fifty day moving average of $10.18 and a 200 day moving average of $6.66.
Axe Compute (NASDAQ:AGPU – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.87) EPS for the quarter. Axe Compute had a negative return on equity of 1,606.56% and a negative net margin of 7,769.61%. The company had revenue of $3.21 million during the quarter.
Institutional Trading of Axe Compute
An institutional investor recently bought a new stake in Axe Compute stock. Vise Technologies Inc. bought a new stake in Axe Compute Inc (NASDAQ:AGPU – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 53,848 shares of the company’s stock, valued at approximately $612,000. Vise Technologies Inc. owned 0.46% of Axe Compute as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 9.04% of the company’s stock.
About Axe Compute
Predictive Oncology Inc, a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation.
See Also
- Five stocks we like better than Axe Compute
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Axe Compute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axe Compute and related companies with MarketBeat.com's FREE daily email newsletter.
